Research ArticleArticle
Open Access
Ultrasonographic and Clinical Assessment of Peripheral Enthesitis in Patients with Psoriatic Arthritis, Psoriasis, and Fibromyalgia Syndrome: The ULISSE Study
Pierluigi Macchioni, Carlo Salvarani, Niccolò Possemato, Marwin Gutierrez, Walter Grassi, Stefania Gasparini, Carlo Perricone, Fabio Massimo Perrotta, Rosa Daniela Grembiale, Caterina Bruno, Cesare Tripolino, Marcello Govoni, Giovanni Ciancio, Ilaria Farina, Roberta Ramonda, Paola Frallonardo, Francesca Desiati, Raffaele Scarpa, Luisa Costa, Alen Zabotti, Salvatore De Vita, Rita Maria D’Attino, Giuliana Gualberti, Rocco Merolla, Umberto di Luzio Paparatti, Raffaella Aldigeri and Antonio Marchesoni
The Journal of Rheumatology March 2019, jrheum.171411; DOI: https://doi.org/10.3899/jrheum.171411
Pierluigi Macchioni
From the Azienda USL-Institute for Research and Health Care (IRCCS) di Reggio Emilia; Università di Modena e Reggio Emilia, Reggio Emilia, Italy; Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation, Mexico City, Mexico; Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani, Jesi; Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University, Rome; Dipartimento di Medicina e Scienze della salute, Università degli studi del Molise, Campobasso; Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro, Catanzaro; Rheumatology Unit, Department of Medical Sciences, University of Ferrara; Azienda Ospedaliero-Universitaria S. Anna — Ferrara; Rheumatology Unit, Department of Medicine DIMED, University of Padua, Padua; Day Hospital of Rheumatology, Azienda Socio Sanitaria Territoriale (ASST) Gaetano Pini-Centro Specialistico Ortopedico (CTO), Milan; Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples; Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia,” Udine; AbbVie Srl, Rome; Department of Medicine and Surgery, University of Parma, Parma, Italy. R.M. D’Attino, G. Gualberti, and R. Merolla are employees of AbbVie and may own AbbVie stocks/options. U. di Luzio Paparatti was an employee of AbbVie and may own AbbVie stocks/options. AbbVie participated in the design, study conduct, and financial support for the study, as well as in interpretation of the data, review, and approval of the manuscript. Dr. C. Salvarani has acted as a consultant for AbbVie, MSD, Pfizer Inc, Roche, Celgene, and Novartis. Dr. W. Grassi has received honoraria and speaker fees from AbbVie, Roche, BMS, Pfizer, UCB, and MSD. Dr. M. Gutierrez has attended advisory board meetings, held scientific consultancies, and has obtained consulting fees from AbbVie, UCB Pharma, Esaote SpA, Bristol-Myers Squibb, Novartis, and Merck Sharp & Dohme. P. Macchioni, MD, Azienda USL-IRCCS di Reggio Emilia; C. Salvarani, MD, Azienda USL-IRCCS di Reggio Emilia, and Università di Modena e Reggio Emilia; N. Possemato, MD, Azienda USL-IRCCS di Reggio Emilia; M. Gutierrez, MD, Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation; W. Grassi, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; S. Gasparini, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; C. Perricone, MD, Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University; F.M. Perrotta, MD, Dipartimento di Medicina e Scienze della Salute, Università degli studi del Molise; R.D. Grembiale, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Bruno, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Tripolino, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; M. Govoni, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; G. Ciancio, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; I. Farina, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; R. Ramonda, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; P. Frallonardo, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; F. Desiati, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO; R. Scarpa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; L. Costa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; A. Zabotti, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; S. De Vita, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; R.M. D’Attino, MD, AbbVie Srl; G. Gualberti, PhD, AbbVie Srl; R. Merolla, MD, AbbVie Srl; U. di Luzio Paparatti, MD, AbbVie Srl; R. Aldigeri, BSc, Department of Medicine and Surgery, University of Parma; A. Marchesoni, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO. Address correspondence to Dr. A. Marchesoni, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO, Piazza Andrea Ferrari 1, 20122 Milan, Italy. E-mail: Antonio.Marchesoni@asst-pini-cto.it. Full Release Article. For details see Reprints and Permissions at jrheum.org Accepted for publication October 29, 2018.
Carlo Salvarani
From the Azienda USL-Institute for Research and Health Care (IRCCS) di Reggio Emilia; Università di Modena e Reggio Emilia, Reggio Emilia, Italy; Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation, Mexico City, Mexico; Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani, Jesi; Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University, Rome; Dipartimento di Medicina e Scienze della salute, Università degli studi del Molise, Campobasso; Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro, Catanzaro; Rheumatology Unit, Department of Medical Sciences, University of Ferrara; Azienda Ospedaliero-Universitaria S. Anna — Ferrara; Rheumatology Unit, Department of Medicine DIMED, University of Padua, Padua; Day Hospital of Rheumatology, Azienda Socio Sanitaria Territoriale (ASST) Gaetano Pini-Centro Specialistico Ortopedico (CTO), Milan; Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples; Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia,” Udine; AbbVie Srl, Rome; Department of Medicine and Surgery, University of Parma, Parma, Italy. R.M. D’Attino, G. Gualberti, and R. Merolla are employees of AbbVie and may own AbbVie stocks/options. U. di Luzio Paparatti was an employee of AbbVie and may own AbbVie stocks/options. AbbVie participated in the design, study conduct, and financial support for the study, as well as in interpretation of the data, review, and approval of the manuscript. Dr. C. Salvarani has acted as a consultant for AbbVie, MSD, Pfizer Inc, Roche, Celgene, and Novartis. Dr. W. Grassi has received honoraria and speaker fees from AbbVie, Roche, BMS, Pfizer, UCB, and MSD. Dr. M. Gutierrez has attended advisory board meetings, held scientific consultancies, and has obtained consulting fees from AbbVie, UCB Pharma, Esaote SpA, Bristol-Myers Squibb, Novartis, and Merck Sharp & Dohme. P. Macchioni, MD, Azienda USL-IRCCS di Reggio Emilia; C. Salvarani, MD, Azienda USL-IRCCS di Reggio Emilia, and Università di Modena e Reggio Emilia; N. Possemato, MD, Azienda USL-IRCCS di Reggio Emilia; M. Gutierrez, MD, Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation; W. Grassi, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; S. Gasparini, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; C. Perricone, MD, Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University; F.M. Perrotta, MD, Dipartimento di Medicina e Scienze della Salute, Università degli studi del Molise; R.D. Grembiale, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Bruno, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Tripolino, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; M. Govoni, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; G. Ciancio, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; I. Farina, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; R. Ramonda, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; P. Frallonardo, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; F. Desiati, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO; R. Scarpa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; L. Costa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; A. Zabotti, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; S. De Vita, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; R.M. D’Attino, MD, AbbVie Srl; G. Gualberti, PhD, AbbVie Srl; R. Merolla, MD, AbbVie Srl; U. di Luzio Paparatti, MD, AbbVie Srl; R. Aldigeri, BSc, Department of Medicine and Surgery, University of Parma; A. Marchesoni, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO. Address correspondence to Dr. A. Marchesoni, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO, Piazza Andrea Ferrari 1, 20122 Milan, Italy. E-mail: Antonio.Marchesoni@asst-pini-cto.it. Full Release Article. For details see Reprints and Permissions at jrheum.org Accepted for publication October 29, 2018.
Niccolò Possemato
From the Azienda USL-Institute for Research and Health Care (IRCCS) di Reggio Emilia; Università di Modena e Reggio Emilia, Reggio Emilia, Italy; Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation, Mexico City, Mexico; Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani, Jesi; Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University, Rome; Dipartimento di Medicina e Scienze della salute, Università degli studi del Molise, Campobasso; Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro, Catanzaro; Rheumatology Unit, Department of Medical Sciences, University of Ferrara; Azienda Ospedaliero-Universitaria S. Anna — Ferrara; Rheumatology Unit, Department of Medicine DIMED, University of Padua, Padua; Day Hospital of Rheumatology, Azienda Socio Sanitaria Territoriale (ASST) Gaetano Pini-Centro Specialistico Ortopedico (CTO), Milan; Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples; Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia,” Udine; AbbVie Srl, Rome; Department of Medicine and Surgery, University of Parma, Parma, Italy. R.M. D’Attino, G. Gualberti, and R. Merolla are employees of AbbVie and may own AbbVie stocks/options. U. di Luzio Paparatti was an employee of AbbVie and may own AbbVie stocks/options. AbbVie participated in the design, study conduct, and financial support for the study, as well as in interpretation of the data, review, and approval of the manuscript. Dr. C. Salvarani has acted as a consultant for AbbVie, MSD, Pfizer Inc, Roche, Celgene, and Novartis. Dr. W. Grassi has received honoraria and speaker fees from AbbVie, Roche, BMS, Pfizer, UCB, and MSD. Dr. M. Gutierrez has attended advisory board meetings, held scientific consultancies, and has obtained consulting fees from AbbVie, UCB Pharma, Esaote SpA, Bristol-Myers Squibb, Novartis, and Merck Sharp & Dohme. P. Macchioni, MD, Azienda USL-IRCCS di Reggio Emilia; C. Salvarani, MD, Azienda USL-IRCCS di Reggio Emilia, and Università di Modena e Reggio Emilia; N. Possemato, MD, Azienda USL-IRCCS di Reggio Emilia; M. Gutierrez, MD, Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation; W. Grassi, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; S. Gasparini, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; C. Perricone, MD, Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University; F.M. Perrotta, MD, Dipartimento di Medicina e Scienze della Salute, Università degli studi del Molise; R.D. Grembiale, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Bruno, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Tripolino, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; M. Govoni, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; G. Ciancio, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; I. Farina, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; R. Ramonda, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; P. Frallonardo, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; F. Desiati, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO; R. Scarpa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; L. Costa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; A. Zabotti, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; S. De Vita, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; R.M. D’Attino, MD, AbbVie Srl; G. Gualberti, PhD, AbbVie Srl; R. Merolla, MD, AbbVie Srl; U. di Luzio Paparatti, MD, AbbVie Srl; R. Aldigeri, BSc, Department of Medicine and Surgery, University of Parma; A. Marchesoni, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO. Address correspondence to Dr. A. Marchesoni, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO, Piazza Andrea Ferrari 1, 20122 Milan, Italy. E-mail: Antonio.Marchesoni@asst-pini-cto.it. Full Release Article. For details see Reprints and Permissions at jrheum.org Accepted for publication October 29, 2018.
Marwin Gutierrez
From the Azienda USL-Institute for Research and Health Care (IRCCS) di Reggio Emilia; Università di Modena e Reggio Emilia, Reggio Emilia, Italy; Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation, Mexico City, Mexico; Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani, Jesi; Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University, Rome; Dipartimento di Medicina e Scienze della salute, Università degli studi del Molise, Campobasso; Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro, Catanzaro; Rheumatology Unit, Department of Medical Sciences, University of Ferrara; Azienda Ospedaliero-Universitaria S. Anna — Ferrara; Rheumatology Unit, Department of Medicine DIMED, University of Padua, Padua; Day Hospital of Rheumatology, Azienda Socio Sanitaria Territoriale (ASST) Gaetano Pini-Centro Specialistico Ortopedico (CTO), Milan; Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples; Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia,” Udine; AbbVie Srl, Rome; Department of Medicine and Surgery, University of Parma, Parma, Italy. R.M. D’Attino, G. Gualberti, and R. Merolla are employees of AbbVie and may own AbbVie stocks/options. U. di Luzio Paparatti was an employee of AbbVie and may own AbbVie stocks/options. AbbVie participated in the design, study conduct, and financial support for the study, as well as in interpretation of the data, review, and approval of the manuscript. Dr. C. Salvarani has acted as a consultant for AbbVie, MSD, Pfizer Inc, Roche, Celgene, and Novartis. Dr. W. Grassi has received honoraria and speaker fees from AbbVie, Roche, BMS, Pfizer, UCB, and MSD. Dr. M. Gutierrez has attended advisory board meetings, held scientific consultancies, and has obtained consulting fees from AbbVie, UCB Pharma, Esaote SpA, Bristol-Myers Squibb, Novartis, and Merck Sharp & Dohme. P. Macchioni, MD, Azienda USL-IRCCS di Reggio Emilia; C. Salvarani, MD, Azienda USL-IRCCS di Reggio Emilia, and Università di Modena e Reggio Emilia; N. Possemato, MD, Azienda USL-IRCCS di Reggio Emilia; M. Gutierrez, MD, Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation; W. Grassi, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; S. Gasparini, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; C. Perricone, MD, Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University; F.M. Perrotta, MD, Dipartimento di Medicina e Scienze della Salute, Università degli studi del Molise; R.D. Grembiale, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Bruno, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Tripolino, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; M. Govoni, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; G. Ciancio, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; I. Farina, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; R. Ramonda, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; P. Frallonardo, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; F. Desiati, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO; R. Scarpa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; L. Costa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; A. Zabotti, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; S. De Vita, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; R.M. D’Attino, MD, AbbVie Srl; G. Gualberti, PhD, AbbVie Srl; R. Merolla, MD, AbbVie Srl; U. di Luzio Paparatti, MD, AbbVie Srl; R. Aldigeri, BSc, Department of Medicine and Surgery, University of Parma; A. Marchesoni, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO. Address correspondence to Dr. A. Marchesoni, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO, Piazza Andrea Ferrari 1, 20122 Milan, Italy. E-mail: Antonio.Marchesoni@asst-pini-cto.it. Full Release Article. For details see Reprints and Permissions at jrheum.org Accepted for publication October 29, 2018.
Walter Grassi
From the Azienda USL-Institute for Research and Health Care (IRCCS) di Reggio Emilia; Università di Modena e Reggio Emilia, Reggio Emilia, Italy; Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation, Mexico City, Mexico; Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani, Jesi; Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University, Rome; Dipartimento di Medicina e Scienze della salute, Università degli studi del Molise, Campobasso; Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro, Catanzaro; Rheumatology Unit, Department of Medical Sciences, University of Ferrara; Azienda Ospedaliero-Universitaria S. Anna — Ferrara; Rheumatology Unit, Department of Medicine DIMED, University of Padua, Padua; Day Hospital of Rheumatology, Azienda Socio Sanitaria Territoriale (ASST) Gaetano Pini-Centro Specialistico Ortopedico (CTO), Milan; Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples; Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia,” Udine; AbbVie Srl, Rome; Department of Medicine and Surgery, University of Parma, Parma, Italy. R.M. D’Attino, G. Gualberti, and R. Merolla are employees of AbbVie and may own AbbVie stocks/options. U. di Luzio Paparatti was an employee of AbbVie and may own AbbVie stocks/options. AbbVie participated in the design, study conduct, and financial support for the study, as well as in interpretation of the data, review, and approval of the manuscript. Dr. C. Salvarani has acted as a consultant for AbbVie, MSD, Pfizer Inc, Roche, Celgene, and Novartis. Dr. W. Grassi has received honoraria and speaker fees from AbbVie, Roche, BMS, Pfizer, UCB, and MSD. Dr. M. Gutierrez has attended advisory board meetings, held scientific consultancies, and has obtained consulting fees from AbbVie, UCB Pharma, Esaote SpA, Bristol-Myers Squibb, Novartis, and Merck Sharp & Dohme. P. Macchioni, MD, Azienda USL-IRCCS di Reggio Emilia; C. Salvarani, MD, Azienda USL-IRCCS di Reggio Emilia, and Università di Modena e Reggio Emilia; N. Possemato, MD, Azienda USL-IRCCS di Reggio Emilia; M. Gutierrez, MD, Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation; W. Grassi, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; S. Gasparini, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; C. Perricone, MD, Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University; F.M. Perrotta, MD, Dipartimento di Medicina e Scienze della Salute, Università degli studi del Molise; R.D. Grembiale, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Bruno, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Tripolino, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; M. Govoni, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; G. Ciancio, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; I. Farina, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; R. Ramonda, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; P. Frallonardo, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; F. Desiati, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO; R. Scarpa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; L. Costa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; A. Zabotti, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; S. De Vita, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; R.M. D’Attino, MD, AbbVie Srl; G. Gualberti, PhD, AbbVie Srl; R. Merolla, MD, AbbVie Srl; U. di Luzio Paparatti, MD, AbbVie Srl; R. Aldigeri, BSc, Department of Medicine and Surgery, University of Parma; A. Marchesoni, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO. Address correspondence to Dr. A. Marchesoni, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO, Piazza Andrea Ferrari 1, 20122 Milan, Italy. E-mail: Antonio.Marchesoni@asst-pini-cto.it. Full Release Article. For details see Reprints and Permissions at jrheum.org Accepted for publication October 29, 2018.
Stefania Gasparini
From the Azienda USL-Institute for Research and Health Care (IRCCS) di Reggio Emilia; Università di Modena e Reggio Emilia, Reggio Emilia, Italy; Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation, Mexico City, Mexico; Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani, Jesi; Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University, Rome; Dipartimento di Medicina e Scienze della salute, Università degli studi del Molise, Campobasso; Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro, Catanzaro; Rheumatology Unit, Department of Medical Sciences, University of Ferrara; Azienda Ospedaliero-Universitaria S. Anna — Ferrara; Rheumatology Unit, Department of Medicine DIMED, University of Padua, Padua; Day Hospital of Rheumatology, Azienda Socio Sanitaria Territoriale (ASST) Gaetano Pini-Centro Specialistico Ortopedico (CTO), Milan; Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples; Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia,” Udine; AbbVie Srl, Rome; Department of Medicine and Surgery, University of Parma, Parma, Italy. R.M. D’Attino, G. Gualberti, and R. Merolla are employees of AbbVie and may own AbbVie stocks/options. U. di Luzio Paparatti was an employee of AbbVie and may own AbbVie stocks/options. AbbVie participated in the design, study conduct, and financial support for the study, as well as in interpretation of the data, review, and approval of the manuscript. Dr. C. Salvarani has acted as a consultant for AbbVie, MSD, Pfizer Inc, Roche, Celgene, and Novartis. Dr. W. Grassi has received honoraria and speaker fees from AbbVie, Roche, BMS, Pfizer, UCB, and MSD. Dr. M. Gutierrez has attended advisory board meetings, held scientific consultancies, and has obtained consulting fees from AbbVie, UCB Pharma, Esaote SpA, Bristol-Myers Squibb, Novartis, and Merck Sharp & Dohme. P. Macchioni, MD, Azienda USL-IRCCS di Reggio Emilia; C. Salvarani, MD, Azienda USL-IRCCS di Reggio Emilia, and Università di Modena e Reggio Emilia; N. Possemato, MD, Azienda USL-IRCCS di Reggio Emilia; M. Gutierrez, MD, Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation; W. Grassi, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; S. Gasparini, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; C. Perricone, MD, Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University; F.M. Perrotta, MD, Dipartimento di Medicina e Scienze della Salute, Università degli studi del Molise; R.D. Grembiale, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Bruno, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Tripolino, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; M. Govoni, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; G. Ciancio, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; I. Farina, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; R. Ramonda, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; P. Frallonardo, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; F. Desiati, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO; R. Scarpa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; L. Costa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; A. Zabotti, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; S. De Vita, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; R.M. D’Attino, MD, AbbVie Srl; G. Gualberti, PhD, AbbVie Srl; R. Merolla, MD, AbbVie Srl; U. di Luzio Paparatti, MD, AbbVie Srl; R. Aldigeri, BSc, Department of Medicine and Surgery, University of Parma; A. Marchesoni, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO. Address correspondence to Dr. A. Marchesoni, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO, Piazza Andrea Ferrari 1, 20122 Milan, Italy. E-mail: Antonio.Marchesoni@asst-pini-cto.it. Full Release Article. For details see Reprints and Permissions at jrheum.org Accepted for publication October 29, 2018.
Carlo Perricone
From the Azienda USL-Institute for Research and Health Care (IRCCS) di Reggio Emilia; Università di Modena e Reggio Emilia, Reggio Emilia, Italy; Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation, Mexico City, Mexico; Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani, Jesi; Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University, Rome; Dipartimento di Medicina e Scienze della salute, Università degli studi del Molise, Campobasso; Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro, Catanzaro; Rheumatology Unit, Department of Medical Sciences, University of Ferrara; Azienda Ospedaliero-Universitaria S. Anna — Ferrara; Rheumatology Unit, Department of Medicine DIMED, University of Padua, Padua; Day Hospital of Rheumatology, Azienda Socio Sanitaria Territoriale (ASST) Gaetano Pini-Centro Specialistico Ortopedico (CTO), Milan; Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples; Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia,” Udine; AbbVie Srl, Rome; Department of Medicine and Surgery, University of Parma, Parma, Italy. R.M. D’Attino, G. Gualberti, and R. Merolla are employees of AbbVie and may own AbbVie stocks/options. U. di Luzio Paparatti was an employee of AbbVie and may own AbbVie stocks/options. AbbVie participated in the design, study conduct, and financial support for the study, as well as in interpretation of the data, review, and approval of the manuscript. Dr. C. Salvarani has acted as a consultant for AbbVie, MSD, Pfizer Inc, Roche, Celgene, and Novartis. Dr. W. Grassi has received honoraria and speaker fees from AbbVie, Roche, BMS, Pfizer, UCB, and MSD. Dr. M. Gutierrez has attended advisory board meetings, held scientific consultancies, and has obtained consulting fees from AbbVie, UCB Pharma, Esaote SpA, Bristol-Myers Squibb, Novartis, and Merck Sharp & Dohme. P. Macchioni, MD, Azienda USL-IRCCS di Reggio Emilia; C. Salvarani, MD, Azienda USL-IRCCS di Reggio Emilia, and Università di Modena e Reggio Emilia; N. Possemato, MD, Azienda USL-IRCCS di Reggio Emilia; M. Gutierrez, MD, Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation; W. Grassi, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; S. Gasparini, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; C. Perricone, MD, Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University; F.M. Perrotta, MD, Dipartimento di Medicina e Scienze della Salute, Università degli studi del Molise; R.D. Grembiale, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Bruno, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Tripolino, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; M. Govoni, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; G. Ciancio, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; I. Farina, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; R. Ramonda, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; P. Frallonardo, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; F. Desiati, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO; R. Scarpa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; L. Costa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; A. Zabotti, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; S. De Vita, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; R.M. D’Attino, MD, AbbVie Srl; G. Gualberti, PhD, AbbVie Srl; R. Merolla, MD, AbbVie Srl; U. di Luzio Paparatti, MD, AbbVie Srl; R. Aldigeri, BSc, Department of Medicine and Surgery, University of Parma; A. Marchesoni, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO. Address correspondence to Dr. A. Marchesoni, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO, Piazza Andrea Ferrari 1, 20122 Milan, Italy. E-mail: Antonio.Marchesoni@asst-pini-cto.it. Full Release Article. For details see Reprints and Permissions at jrheum.org Accepted for publication October 29, 2018.
Fabio Massimo Perrotta
From the Azienda USL-Institute for Research and Health Care (IRCCS) di Reggio Emilia; Università di Modena e Reggio Emilia, Reggio Emilia, Italy; Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation, Mexico City, Mexico; Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani, Jesi; Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University, Rome; Dipartimento di Medicina e Scienze della salute, Università degli studi del Molise, Campobasso; Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro, Catanzaro; Rheumatology Unit, Department of Medical Sciences, University of Ferrara; Azienda Ospedaliero-Universitaria S. Anna — Ferrara; Rheumatology Unit, Department of Medicine DIMED, University of Padua, Padua; Day Hospital of Rheumatology, Azienda Socio Sanitaria Territoriale (ASST) Gaetano Pini-Centro Specialistico Ortopedico (CTO), Milan; Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples; Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia,” Udine; AbbVie Srl, Rome; Department of Medicine and Surgery, University of Parma, Parma, Italy. R.M. D’Attino, G. Gualberti, and R. Merolla are employees of AbbVie and may own AbbVie stocks/options. U. di Luzio Paparatti was an employee of AbbVie and may own AbbVie stocks/options. AbbVie participated in the design, study conduct, and financial support for the study, as well as in interpretation of the data, review, and approval of the manuscript. Dr. C. Salvarani has acted as a consultant for AbbVie, MSD, Pfizer Inc, Roche, Celgene, and Novartis. Dr. W. Grassi has received honoraria and speaker fees from AbbVie, Roche, BMS, Pfizer, UCB, and MSD. Dr. M. Gutierrez has attended advisory board meetings, held scientific consultancies, and has obtained consulting fees from AbbVie, UCB Pharma, Esaote SpA, Bristol-Myers Squibb, Novartis, and Merck Sharp & Dohme. P. Macchioni, MD, Azienda USL-IRCCS di Reggio Emilia; C. Salvarani, MD, Azienda USL-IRCCS di Reggio Emilia, and Università di Modena e Reggio Emilia; N. Possemato, MD, Azienda USL-IRCCS di Reggio Emilia; M. Gutierrez, MD, Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation; W. Grassi, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; S. Gasparini, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; C. Perricone, MD, Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University; F.M. Perrotta, MD, Dipartimento di Medicina e Scienze della Salute, Università degli studi del Molise; R.D. Grembiale, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Bruno, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Tripolino, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; M. Govoni, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; G. Ciancio, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; I. Farina, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; R. Ramonda, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; P. Frallonardo, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; F. Desiati, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO; R. Scarpa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; L. Costa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; A. Zabotti, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; S. De Vita, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; R.M. D’Attino, MD, AbbVie Srl; G. Gualberti, PhD, AbbVie Srl; R. Merolla, MD, AbbVie Srl; U. di Luzio Paparatti, MD, AbbVie Srl; R. Aldigeri, BSc, Department of Medicine and Surgery, University of Parma; A. Marchesoni, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO. Address correspondence to Dr. A. Marchesoni, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO, Piazza Andrea Ferrari 1, 20122 Milan, Italy. E-mail: Antonio.Marchesoni@asst-pini-cto.it. Full Release Article. For details see Reprints and Permissions at jrheum.org Accepted for publication October 29, 2018.
Rosa Daniela Grembiale
From the Azienda USL-Institute for Research and Health Care (IRCCS) di Reggio Emilia; Università di Modena e Reggio Emilia, Reggio Emilia, Italy; Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation, Mexico City, Mexico; Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani, Jesi; Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University, Rome; Dipartimento di Medicina e Scienze della salute, Università degli studi del Molise, Campobasso; Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro, Catanzaro; Rheumatology Unit, Department of Medical Sciences, University of Ferrara; Azienda Ospedaliero-Universitaria S. Anna — Ferrara; Rheumatology Unit, Department of Medicine DIMED, University of Padua, Padua; Day Hospital of Rheumatology, Azienda Socio Sanitaria Territoriale (ASST) Gaetano Pini-Centro Specialistico Ortopedico (CTO), Milan; Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples; Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia,” Udine; AbbVie Srl, Rome; Department of Medicine and Surgery, University of Parma, Parma, Italy. R.M. D’Attino, G. Gualberti, and R. Merolla are employees of AbbVie and may own AbbVie stocks/options. U. di Luzio Paparatti was an employee of AbbVie and may own AbbVie stocks/options. AbbVie participated in the design, study conduct, and financial support for the study, as well as in interpretation of the data, review, and approval of the manuscript. Dr. C. Salvarani has acted as a consultant for AbbVie, MSD, Pfizer Inc, Roche, Celgene, and Novartis. Dr. W. Grassi has received honoraria and speaker fees from AbbVie, Roche, BMS, Pfizer, UCB, and MSD. Dr. M. Gutierrez has attended advisory board meetings, held scientific consultancies, and has obtained consulting fees from AbbVie, UCB Pharma, Esaote SpA, Bristol-Myers Squibb, Novartis, and Merck Sharp & Dohme. P. Macchioni, MD, Azienda USL-IRCCS di Reggio Emilia; C. Salvarani, MD, Azienda USL-IRCCS di Reggio Emilia, and Università di Modena e Reggio Emilia; N. Possemato, MD, Azienda USL-IRCCS di Reggio Emilia; M. Gutierrez, MD, Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation; W. Grassi, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; S. Gasparini, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; C. Perricone, MD, Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University; F.M. Perrotta, MD, Dipartimento di Medicina e Scienze della Salute, Università degli studi del Molise; R.D. Grembiale, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Bruno, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Tripolino, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; M. Govoni, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; G. Ciancio, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; I. Farina, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; R. Ramonda, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; P. Frallonardo, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; F. Desiati, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO; R. Scarpa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; L. Costa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; A. Zabotti, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; S. De Vita, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; R.M. D’Attino, MD, AbbVie Srl; G. Gualberti, PhD, AbbVie Srl; R. Merolla, MD, AbbVie Srl; U. di Luzio Paparatti, MD, AbbVie Srl; R. Aldigeri, BSc, Department of Medicine and Surgery, University of Parma; A. Marchesoni, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO. Address correspondence to Dr. A. Marchesoni, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO, Piazza Andrea Ferrari 1, 20122 Milan, Italy. E-mail: Antonio.Marchesoni@asst-pini-cto.it. Full Release Article. For details see Reprints and Permissions at jrheum.org Accepted for publication October 29, 2018.
Caterina Bruno
From the Azienda USL-Institute for Research and Health Care (IRCCS) di Reggio Emilia; Università di Modena e Reggio Emilia, Reggio Emilia, Italy; Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation, Mexico City, Mexico; Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani, Jesi; Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University, Rome; Dipartimento di Medicina e Scienze della salute, Università degli studi del Molise, Campobasso; Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro, Catanzaro; Rheumatology Unit, Department of Medical Sciences, University of Ferrara; Azienda Ospedaliero-Universitaria S. Anna — Ferrara; Rheumatology Unit, Department of Medicine DIMED, University of Padua, Padua; Day Hospital of Rheumatology, Azienda Socio Sanitaria Territoriale (ASST) Gaetano Pini-Centro Specialistico Ortopedico (CTO), Milan; Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples; Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia,” Udine; AbbVie Srl, Rome; Department of Medicine and Surgery, University of Parma, Parma, Italy. R.M. D’Attino, G. Gualberti, and R. Merolla are employees of AbbVie and may own AbbVie stocks/options. U. di Luzio Paparatti was an employee of AbbVie and may own AbbVie stocks/options. AbbVie participated in the design, study conduct, and financial support for the study, as well as in interpretation of the data, review, and approval of the manuscript. Dr. C. Salvarani has acted as a consultant for AbbVie, MSD, Pfizer Inc, Roche, Celgene, and Novartis. Dr. W. Grassi has received honoraria and speaker fees from AbbVie, Roche, BMS, Pfizer, UCB, and MSD. Dr. M. Gutierrez has attended advisory board meetings, held scientific consultancies, and has obtained consulting fees from AbbVie, UCB Pharma, Esaote SpA, Bristol-Myers Squibb, Novartis, and Merck Sharp & Dohme. P. Macchioni, MD, Azienda USL-IRCCS di Reggio Emilia; C. Salvarani, MD, Azienda USL-IRCCS di Reggio Emilia, and Università di Modena e Reggio Emilia; N. Possemato, MD, Azienda USL-IRCCS di Reggio Emilia; M. Gutierrez, MD, Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation; W. Grassi, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; S. Gasparini, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; C. Perricone, MD, Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University; F.M. Perrotta, MD, Dipartimento di Medicina e Scienze della Salute, Università degli studi del Molise; R.D. Grembiale, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Bruno, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Tripolino, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; M. Govoni, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; G. Ciancio, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; I. Farina, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; R. Ramonda, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; P. Frallonardo, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; F. Desiati, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO; R. Scarpa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; L. Costa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; A. Zabotti, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; S. De Vita, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; R.M. D’Attino, MD, AbbVie Srl; G. Gualberti, PhD, AbbVie Srl; R. Merolla, MD, AbbVie Srl; U. di Luzio Paparatti, MD, AbbVie Srl; R. Aldigeri, BSc, Department of Medicine and Surgery, University of Parma; A. Marchesoni, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO. Address correspondence to Dr. A. Marchesoni, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO, Piazza Andrea Ferrari 1, 20122 Milan, Italy. E-mail: Antonio.Marchesoni@asst-pini-cto.it. Full Release Article. For details see Reprints and Permissions at jrheum.org Accepted for publication October 29, 2018.
Cesare Tripolino
From the Azienda USL-Institute for Research and Health Care (IRCCS) di Reggio Emilia; Università di Modena e Reggio Emilia, Reggio Emilia, Italy; Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation, Mexico City, Mexico; Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani, Jesi; Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University, Rome; Dipartimento di Medicina e Scienze della salute, Università degli studi del Molise, Campobasso; Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro, Catanzaro; Rheumatology Unit, Department of Medical Sciences, University of Ferrara; Azienda Ospedaliero-Universitaria S. Anna — Ferrara; Rheumatology Unit, Department of Medicine DIMED, University of Padua, Padua; Day Hospital of Rheumatology, Azienda Socio Sanitaria Territoriale (ASST) Gaetano Pini-Centro Specialistico Ortopedico (CTO), Milan; Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples; Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia,” Udine; AbbVie Srl, Rome; Department of Medicine and Surgery, University of Parma, Parma, Italy. R.M. D’Attino, G. Gualberti, and R. Merolla are employees of AbbVie and may own AbbVie stocks/options. U. di Luzio Paparatti was an employee of AbbVie and may own AbbVie stocks/options. AbbVie participated in the design, study conduct, and financial support for the study, as well as in interpretation of the data, review, and approval of the manuscript. Dr. C. Salvarani has acted as a consultant for AbbVie, MSD, Pfizer Inc, Roche, Celgene, and Novartis. Dr. W. Grassi has received honoraria and speaker fees from AbbVie, Roche, BMS, Pfizer, UCB, and MSD. Dr. M. Gutierrez has attended advisory board meetings, held scientific consultancies, and has obtained consulting fees from AbbVie, UCB Pharma, Esaote SpA, Bristol-Myers Squibb, Novartis, and Merck Sharp & Dohme. P. Macchioni, MD, Azienda USL-IRCCS di Reggio Emilia; C. Salvarani, MD, Azienda USL-IRCCS di Reggio Emilia, and Università di Modena e Reggio Emilia; N. Possemato, MD, Azienda USL-IRCCS di Reggio Emilia; M. Gutierrez, MD, Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation; W. Grassi, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; S. Gasparini, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; C. Perricone, MD, Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University; F.M. Perrotta, MD, Dipartimento di Medicina e Scienze della Salute, Università degli studi del Molise; R.D. Grembiale, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Bruno, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Tripolino, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; M. Govoni, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; G. Ciancio, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; I. Farina, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; R. Ramonda, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; P. Frallonardo, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; F. Desiati, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO; R. Scarpa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; L. Costa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; A. Zabotti, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; S. De Vita, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; R.M. D’Attino, MD, AbbVie Srl; G. Gualberti, PhD, AbbVie Srl; R. Merolla, MD, AbbVie Srl; U. di Luzio Paparatti, MD, AbbVie Srl; R. Aldigeri, BSc, Department of Medicine and Surgery, University of Parma; A. Marchesoni, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO. Address correspondence to Dr. A. Marchesoni, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO, Piazza Andrea Ferrari 1, 20122 Milan, Italy. E-mail: Antonio.Marchesoni@asst-pini-cto.it. Full Release Article. For details see Reprints and Permissions at jrheum.org Accepted for publication October 29, 2018.
Marcello Govoni
From the Azienda USL-Institute for Research and Health Care (IRCCS) di Reggio Emilia; Università di Modena e Reggio Emilia, Reggio Emilia, Italy; Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation, Mexico City, Mexico; Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani, Jesi; Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University, Rome; Dipartimento di Medicina e Scienze della salute, Università degli studi del Molise, Campobasso; Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro, Catanzaro; Rheumatology Unit, Department of Medical Sciences, University of Ferrara; Azienda Ospedaliero-Universitaria S. Anna — Ferrara; Rheumatology Unit, Department of Medicine DIMED, University of Padua, Padua; Day Hospital of Rheumatology, Azienda Socio Sanitaria Territoriale (ASST) Gaetano Pini-Centro Specialistico Ortopedico (CTO), Milan; Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples; Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia,” Udine; AbbVie Srl, Rome; Department of Medicine and Surgery, University of Parma, Parma, Italy. R.M. D’Attino, G. Gualberti, and R. Merolla are employees of AbbVie and may own AbbVie stocks/options. U. di Luzio Paparatti was an employee of AbbVie and may own AbbVie stocks/options. AbbVie participated in the design, study conduct, and financial support for the study, as well as in interpretation of the data, review, and approval of the manuscript. Dr. C. Salvarani has acted as a consultant for AbbVie, MSD, Pfizer Inc, Roche, Celgene, and Novartis. Dr. W. Grassi has received honoraria and speaker fees from AbbVie, Roche, BMS, Pfizer, UCB, and MSD. Dr. M. Gutierrez has attended advisory board meetings, held scientific consultancies, and has obtained consulting fees from AbbVie, UCB Pharma, Esaote SpA, Bristol-Myers Squibb, Novartis, and Merck Sharp & Dohme. P. Macchioni, MD, Azienda USL-IRCCS di Reggio Emilia; C. Salvarani, MD, Azienda USL-IRCCS di Reggio Emilia, and Università di Modena e Reggio Emilia; N. Possemato, MD, Azienda USL-IRCCS di Reggio Emilia; M. Gutierrez, MD, Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation; W. Grassi, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; S. Gasparini, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; C. Perricone, MD, Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University; F.M. Perrotta, MD, Dipartimento di Medicina e Scienze della Salute, Università degli studi del Molise; R.D. Grembiale, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Bruno, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Tripolino, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; M. Govoni, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; G. Ciancio, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; I. Farina, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; R. Ramonda, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; P. Frallonardo, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; F. Desiati, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO; R. Scarpa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; L. Costa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; A. Zabotti, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; S. De Vita, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; R.M. D’Attino, MD, AbbVie Srl; G. Gualberti, PhD, AbbVie Srl; R. Merolla, MD, AbbVie Srl; U. di Luzio Paparatti, MD, AbbVie Srl; R. Aldigeri, BSc, Department of Medicine and Surgery, University of Parma; A. Marchesoni, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO. Address correspondence to Dr. A. Marchesoni, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO, Piazza Andrea Ferrari 1, 20122 Milan, Italy. E-mail: Antonio.Marchesoni@asst-pini-cto.it. Full Release Article. For details see Reprints and Permissions at jrheum.org Accepted for publication October 29, 2018.
Giovanni Ciancio
From the Azienda USL-Institute for Research and Health Care (IRCCS) di Reggio Emilia; Università di Modena e Reggio Emilia, Reggio Emilia, Italy; Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation, Mexico City, Mexico; Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani, Jesi; Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University, Rome; Dipartimento di Medicina e Scienze della salute, Università degli studi del Molise, Campobasso; Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro, Catanzaro; Rheumatology Unit, Department of Medical Sciences, University of Ferrara; Azienda Ospedaliero-Universitaria S. Anna — Ferrara; Rheumatology Unit, Department of Medicine DIMED, University of Padua, Padua; Day Hospital of Rheumatology, Azienda Socio Sanitaria Territoriale (ASST) Gaetano Pini-Centro Specialistico Ortopedico (CTO), Milan; Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples; Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia,” Udine; AbbVie Srl, Rome; Department of Medicine and Surgery, University of Parma, Parma, Italy. R.M. D’Attino, G. Gualberti, and R. Merolla are employees of AbbVie and may own AbbVie stocks/options. U. di Luzio Paparatti was an employee of AbbVie and may own AbbVie stocks/options. AbbVie participated in the design, study conduct, and financial support for the study, as well as in interpretation of the data, review, and approval of the manuscript. Dr. C. Salvarani has acted as a consultant for AbbVie, MSD, Pfizer Inc, Roche, Celgene, and Novartis. Dr. W. Grassi has received honoraria and speaker fees from AbbVie, Roche, BMS, Pfizer, UCB, and MSD. Dr. M. Gutierrez has attended advisory board meetings, held scientific consultancies, and has obtained consulting fees from AbbVie, UCB Pharma, Esaote SpA, Bristol-Myers Squibb, Novartis, and Merck Sharp & Dohme. P. Macchioni, MD, Azienda USL-IRCCS di Reggio Emilia; C. Salvarani, MD, Azienda USL-IRCCS di Reggio Emilia, and Università di Modena e Reggio Emilia; N. Possemato, MD, Azienda USL-IRCCS di Reggio Emilia; M. Gutierrez, MD, Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation; W. Grassi, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; S. Gasparini, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; C. Perricone, MD, Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University; F.M. Perrotta, MD, Dipartimento di Medicina e Scienze della Salute, Università degli studi del Molise; R.D. Grembiale, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Bruno, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Tripolino, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; M. Govoni, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; G. Ciancio, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; I. Farina, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; R. Ramonda, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; P. Frallonardo, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; F. Desiati, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO; R. Scarpa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; L. Costa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; A. Zabotti, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; S. De Vita, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; R.M. D’Attino, MD, AbbVie Srl; G. Gualberti, PhD, AbbVie Srl; R. Merolla, MD, AbbVie Srl; U. di Luzio Paparatti, MD, AbbVie Srl; R. Aldigeri, BSc, Department of Medicine and Surgery, University of Parma; A. Marchesoni, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO. Address correspondence to Dr. A. Marchesoni, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO, Piazza Andrea Ferrari 1, 20122 Milan, Italy. E-mail: Antonio.Marchesoni@asst-pini-cto.it. Full Release Article. For details see Reprints and Permissions at jrheum.org Accepted for publication October 29, 2018.
Ilaria Farina
From the Azienda USL-Institute for Research and Health Care (IRCCS) di Reggio Emilia; Università di Modena e Reggio Emilia, Reggio Emilia, Italy; Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation, Mexico City, Mexico; Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani, Jesi; Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University, Rome; Dipartimento di Medicina e Scienze della salute, Università degli studi del Molise, Campobasso; Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro, Catanzaro; Rheumatology Unit, Department of Medical Sciences, University of Ferrara; Azienda Ospedaliero-Universitaria S. Anna — Ferrara; Rheumatology Unit, Department of Medicine DIMED, University of Padua, Padua; Day Hospital of Rheumatology, Azienda Socio Sanitaria Territoriale (ASST) Gaetano Pini-Centro Specialistico Ortopedico (CTO), Milan; Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples; Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia,” Udine; AbbVie Srl, Rome; Department of Medicine and Surgery, University of Parma, Parma, Italy. R.M. D’Attino, G. Gualberti, and R. Merolla are employees of AbbVie and may own AbbVie stocks/options. U. di Luzio Paparatti was an employee of AbbVie and may own AbbVie stocks/options. AbbVie participated in the design, study conduct, and financial support for the study, as well as in interpretation of the data, review, and approval of the manuscript. Dr. C. Salvarani has acted as a consultant for AbbVie, MSD, Pfizer Inc, Roche, Celgene, and Novartis. Dr. W. Grassi has received honoraria and speaker fees from AbbVie, Roche, BMS, Pfizer, UCB, and MSD. Dr. M. Gutierrez has attended advisory board meetings, held scientific consultancies, and has obtained consulting fees from AbbVie, UCB Pharma, Esaote SpA, Bristol-Myers Squibb, Novartis, and Merck Sharp & Dohme. P. Macchioni, MD, Azienda USL-IRCCS di Reggio Emilia; C. Salvarani, MD, Azienda USL-IRCCS di Reggio Emilia, and Università di Modena e Reggio Emilia; N. Possemato, MD, Azienda USL-IRCCS di Reggio Emilia; M. Gutierrez, MD, Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation; W. Grassi, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; S. Gasparini, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; C. Perricone, MD, Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University; F.M. Perrotta, MD, Dipartimento di Medicina e Scienze della Salute, Università degli studi del Molise; R.D. Grembiale, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Bruno, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Tripolino, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; M. Govoni, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; G. Ciancio, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; I. Farina, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; R. Ramonda, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; P. Frallonardo, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; F. Desiati, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO; R. Scarpa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; L. Costa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; A. Zabotti, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; S. De Vita, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; R.M. D’Attino, MD, AbbVie Srl; G. Gualberti, PhD, AbbVie Srl; R. Merolla, MD, AbbVie Srl; U. di Luzio Paparatti, MD, AbbVie Srl; R. Aldigeri, BSc, Department of Medicine and Surgery, University of Parma; A. Marchesoni, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO. Address correspondence to Dr. A. Marchesoni, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO, Piazza Andrea Ferrari 1, 20122 Milan, Italy. E-mail: Antonio.Marchesoni@asst-pini-cto.it. Full Release Article. For details see Reprints and Permissions at jrheum.org Accepted for publication October 29, 2018.
Roberta Ramonda
From the Azienda USL-Institute for Research and Health Care (IRCCS) di Reggio Emilia; Università di Modena e Reggio Emilia, Reggio Emilia, Italy; Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation, Mexico City, Mexico; Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani, Jesi; Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University, Rome; Dipartimento di Medicina e Scienze della salute, Università degli studi del Molise, Campobasso; Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro, Catanzaro; Rheumatology Unit, Department of Medical Sciences, University of Ferrara; Azienda Ospedaliero-Universitaria S. Anna — Ferrara; Rheumatology Unit, Department of Medicine DIMED, University of Padua, Padua; Day Hospital of Rheumatology, Azienda Socio Sanitaria Territoriale (ASST) Gaetano Pini-Centro Specialistico Ortopedico (CTO), Milan; Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples; Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia,” Udine; AbbVie Srl, Rome; Department of Medicine and Surgery, University of Parma, Parma, Italy. R.M. D’Attino, G. Gualberti, and R. Merolla are employees of AbbVie and may own AbbVie stocks/options. U. di Luzio Paparatti was an employee of AbbVie and may own AbbVie stocks/options. AbbVie participated in the design, study conduct, and financial support for the study, as well as in interpretation of the data, review, and approval of the manuscript. Dr. C. Salvarani has acted as a consultant for AbbVie, MSD, Pfizer Inc, Roche, Celgene, and Novartis. Dr. W. Grassi has received honoraria and speaker fees from AbbVie, Roche, BMS, Pfizer, UCB, and MSD. Dr. M. Gutierrez has attended advisory board meetings, held scientific consultancies, and has obtained consulting fees from AbbVie, UCB Pharma, Esaote SpA, Bristol-Myers Squibb, Novartis, and Merck Sharp & Dohme. P. Macchioni, MD, Azienda USL-IRCCS di Reggio Emilia; C. Salvarani, MD, Azienda USL-IRCCS di Reggio Emilia, and Università di Modena e Reggio Emilia; N. Possemato, MD, Azienda USL-IRCCS di Reggio Emilia; M. Gutierrez, MD, Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation; W. Grassi, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; S. Gasparini, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; C. Perricone, MD, Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University; F.M. Perrotta, MD, Dipartimento di Medicina e Scienze della Salute, Università degli studi del Molise; R.D. Grembiale, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Bruno, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Tripolino, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; M. Govoni, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; G. Ciancio, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; I. Farina, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; R. Ramonda, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; P. Frallonardo, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; F. Desiati, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO; R. Scarpa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; L. Costa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; A. Zabotti, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; S. De Vita, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; R.M. D’Attino, MD, AbbVie Srl; G. Gualberti, PhD, AbbVie Srl; R. Merolla, MD, AbbVie Srl; U. di Luzio Paparatti, MD, AbbVie Srl; R. Aldigeri, BSc, Department of Medicine and Surgery, University of Parma; A. Marchesoni, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO. Address correspondence to Dr. A. Marchesoni, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO, Piazza Andrea Ferrari 1, 20122 Milan, Italy. E-mail: Antonio.Marchesoni@asst-pini-cto.it. Full Release Article. For details see Reprints and Permissions at jrheum.org Accepted for publication October 29, 2018.
Paola Frallonardo
From the Azienda USL-Institute for Research and Health Care (IRCCS) di Reggio Emilia; Università di Modena e Reggio Emilia, Reggio Emilia, Italy; Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation, Mexico City, Mexico; Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani, Jesi; Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University, Rome; Dipartimento di Medicina e Scienze della salute, Università degli studi del Molise, Campobasso; Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro, Catanzaro; Rheumatology Unit, Department of Medical Sciences, University of Ferrara; Azienda Ospedaliero-Universitaria S. Anna — Ferrara; Rheumatology Unit, Department of Medicine DIMED, University of Padua, Padua; Day Hospital of Rheumatology, Azienda Socio Sanitaria Territoriale (ASST) Gaetano Pini-Centro Specialistico Ortopedico (CTO), Milan; Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples; Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia,” Udine; AbbVie Srl, Rome; Department of Medicine and Surgery, University of Parma, Parma, Italy. R.M. D’Attino, G. Gualberti, and R. Merolla are employees of AbbVie and may own AbbVie stocks/options. U. di Luzio Paparatti was an employee of AbbVie and may own AbbVie stocks/options. AbbVie participated in the design, study conduct, and financial support for the study, as well as in interpretation of the data, review, and approval of the manuscript. Dr. C. Salvarani has acted as a consultant for AbbVie, MSD, Pfizer Inc, Roche, Celgene, and Novartis. Dr. W. Grassi has received honoraria and speaker fees from AbbVie, Roche, BMS, Pfizer, UCB, and MSD. Dr. M. Gutierrez has attended advisory board meetings, held scientific consultancies, and has obtained consulting fees from AbbVie, UCB Pharma, Esaote SpA, Bristol-Myers Squibb, Novartis, and Merck Sharp & Dohme. P. Macchioni, MD, Azienda USL-IRCCS di Reggio Emilia; C. Salvarani, MD, Azienda USL-IRCCS di Reggio Emilia, and Università di Modena e Reggio Emilia; N. Possemato, MD, Azienda USL-IRCCS di Reggio Emilia; M. Gutierrez, MD, Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation; W. Grassi, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; S. Gasparini, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; C. Perricone, MD, Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University; F.M. Perrotta, MD, Dipartimento di Medicina e Scienze della Salute, Università degli studi del Molise; R.D. Grembiale, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Bruno, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Tripolino, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; M. Govoni, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; G. Ciancio, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; I. Farina, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; R. Ramonda, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; P. Frallonardo, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; F. Desiati, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO; R. Scarpa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; L. Costa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; A. Zabotti, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; S. De Vita, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; R.M. D’Attino, MD, AbbVie Srl; G. Gualberti, PhD, AbbVie Srl; R. Merolla, MD, AbbVie Srl; U. di Luzio Paparatti, MD, AbbVie Srl; R. Aldigeri, BSc, Department of Medicine and Surgery, University of Parma; A. Marchesoni, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO. Address correspondence to Dr. A. Marchesoni, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO, Piazza Andrea Ferrari 1, 20122 Milan, Italy. E-mail: Antonio.Marchesoni@asst-pini-cto.it. Full Release Article. For details see Reprints and Permissions at jrheum.org Accepted for publication October 29, 2018.
Francesca Desiati
From the Azienda USL-Institute for Research and Health Care (IRCCS) di Reggio Emilia; Università di Modena e Reggio Emilia, Reggio Emilia, Italy; Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation, Mexico City, Mexico; Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani, Jesi; Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University, Rome; Dipartimento di Medicina e Scienze della salute, Università degli studi del Molise, Campobasso; Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro, Catanzaro; Rheumatology Unit, Department of Medical Sciences, University of Ferrara; Azienda Ospedaliero-Universitaria S. Anna — Ferrara; Rheumatology Unit, Department of Medicine DIMED, University of Padua, Padua; Day Hospital of Rheumatology, Azienda Socio Sanitaria Territoriale (ASST) Gaetano Pini-Centro Specialistico Ortopedico (CTO), Milan; Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples; Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia,” Udine; AbbVie Srl, Rome; Department of Medicine and Surgery, University of Parma, Parma, Italy. R.M. D’Attino, G. Gualberti, and R. Merolla are employees of AbbVie and may own AbbVie stocks/options. U. di Luzio Paparatti was an employee of AbbVie and may own AbbVie stocks/options. AbbVie participated in the design, study conduct, and financial support for the study, as well as in interpretation of the data, review, and approval of the manuscript. Dr. C. Salvarani has acted as a consultant for AbbVie, MSD, Pfizer Inc, Roche, Celgene, and Novartis. Dr. W. Grassi has received honoraria and speaker fees from AbbVie, Roche, BMS, Pfizer, UCB, and MSD. Dr. M. Gutierrez has attended advisory board meetings, held scientific consultancies, and has obtained consulting fees from AbbVie, UCB Pharma, Esaote SpA, Bristol-Myers Squibb, Novartis, and Merck Sharp & Dohme. P. Macchioni, MD, Azienda USL-IRCCS di Reggio Emilia; C. Salvarani, MD, Azienda USL-IRCCS di Reggio Emilia, and Università di Modena e Reggio Emilia; N. Possemato, MD, Azienda USL-IRCCS di Reggio Emilia; M. Gutierrez, MD, Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation; W. Grassi, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; S. Gasparini, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; C. Perricone, MD, Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University; F.M. Perrotta, MD, Dipartimento di Medicina e Scienze della Salute, Università degli studi del Molise; R.D. Grembiale, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Bruno, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Tripolino, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; M. Govoni, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; G. Ciancio, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; I. Farina, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; R. Ramonda, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; P. Frallonardo, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; F. Desiati, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO; R. Scarpa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; L. Costa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; A. Zabotti, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; S. De Vita, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; R.M. D’Attino, MD, AbbVie Srl; G. Gualberti, PhD, AbbVie Srl; R. Merolla, MD, AbbVie Srl; U. di Luzio Paparatti, MD, AbbVie Srl; R. Aldigeri, BSc, Department of Medicine and Surgery, University of Parma; A. Marchesoni, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO. Address correspondence to Dr. A. Marchesoni, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO, Piazza Andrea Ferrari 1, 20122 Milan, Italy. E-mail: Antonio.Marchesoni@asst-pini-cto.it. Full Release Article. For details see Reprints and Permissions at jrheum.org Accepted for publication October 29, 2018.
Raffaele Scarpa
From the Azienda USL-Institute for Research and Health Care (IRCCS) di Reggio Emilia; Università di Modena e Reggio Emilia, Reggio Emilia, Italy; Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation, Mexico City, Mexico; Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani, Jesi; Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University, Rome; Dipartimento di Medicina e Scienze della salute, Università degli studi del Molise, Campobasso; Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro, Catanzaro; Rheumatology Unit, Department of Medical Sciences, University of Ferrara; Azienda Ospedaliero-Universitaria S. Anna — Ferrara; Rheumatology Unit, Department of Medicine DIMED, University of Padua, Padua; Day Hospital of Rheumatology, Azienda Socio Sanitaria Territoriale (ASST) Gaetano Pini-Centro Specialistico Ortopedico (CTO), Milan; Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples; Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia,” Udine; AbbVie Srl, Rome; Department of Medicine and Surgery, University of Parma, Parma, Italy. R.M. D’Attino, G. Gualberti, and R. Merolla are employees of AbbVie and may own AbbVie stocks/options. U. di Luzio Paparatti was an employee of AbbVie and may own AbbVie stocks/options. AbbVie participated in the design, study conduct, and financial support for the study, as well as in interpretation of the data, review, and approval of the manuscript. Dr. C. Salvarani has acted as a consultant for AbbVie, MSD, Pfizer Inc, Roche, Celgene, and Novartis. Dr. W. Grassi has received honoraria and speaker fees from AbbVie, Roche, BMS, Pfizer, UCB, and MSD. Dr. M. Gutierrez has attended advisory board meetings, held scientific consultancies, and has obtained consulting fees from AbbVie, UCB Pharma, Esaote SpA, Bristol-Myers Squibb, Novartis, and Merck Sharp & Dohme. P. Macchioni, MD, Azienda USL-IRCCS di Reggio Emilia; C. Salvarani, MD, Azienda USL-IRCCS di Reggio Emilia, and Università di Modena e Reggio Emilia; N. Possemato, MD, Azienda USL-IRCCS di Reggio Emilia; M. Gutierrez, MD, Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation; W. Grassi, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; S. Gasparini, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; C. Perricone, MD, Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University; F.M. Perrotta, MD, Dipartimento di Medicina e Scienze della Salute, Università degli studi del Molise; R.D. Grembiale, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Bruno, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Tripolino, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; M. Govoni, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; G. Ciancio, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; I. Farina, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; R. Ramonda, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; P. Frallonardo, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; F. Desiati, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO; R. Scarpa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; L. Costa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; A. Zabotti, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; S. De Vita, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; R.M. D’Attino, MD, AbbVie Srl; G. Gualberti, PhD, AbbVie Srl; R. Merolla, MD, AbbVie Srl; U. di Luzio Paparatti, MD, AbbVie Srl; R. Aldigeri, BSc, Department of Medicine and Surgery, University of Parma; A. Marchesoni, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO. Address correspondence to Dr. A. Marchesoni, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO, Piazza Andrea Ferrari 1, 20122 Milan, Italy. E-mail: Antonio.Marchesoni@asst-pini-cto.it. Full Release Article. For details see Reprints and Permissions at jrheum.org Accepted for publication October 29, 2018.
Luisa Costa
From the Azienda USL-Institute for Research and Health Care (IRCCS) di Reggio Emilia; Università di Modena e Reggio Emilia, Reggio Emilia, Italy; Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation, Mexico City, Mexico; Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani, Jesi; Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University, Rome; Dipartimento di Medicina e Scienze della salute, Università degli studi del Molise, Campobasso; Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro, Catanzaro; Rheumatology Unit, Department of Medical Sciences, University of Ferrara; Azienda Ospedaliero-Universitaria S. Anna — Ferrara; Rheumatology Unit, Department of Medicine DIMED, University of Padua, Padua; Day Hospital of Rheumatology, Azienda Socio Sanitaria Territoriale (ASST) Gaetano Pini-Centro Specialistico Ortopedico (CTO), Milan; Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples; Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia,” Udine; AbbVie Srl, Rome; Department of Medicine and Surgery, University of Parma, Parma, Italy. R.M. D’Attino, G. Gualberti, and R. Merolla are employees of AbbVie and may own AbbVie stocks/options. U. di Luzio Paparatti was an employee of AbbVie and may own AbbVie stocks/options. AbbVie participated in the design, study conduct, and financial support for the study, as well as in interpretation of the data, review, and approval of the manuscript. Dr. C. Salvarani has acted as a consultant for AbbVie, MSD, Pfizer Inc, Roche, Celgene, and Novartis. Dr. W. Grassi has received honoraria and speaker fees from AbbVie, Roche, BMS, Pfizer, UCB, and MSD. Dr. M. Gutierrez has attended advisory board meetings, held scientific consultancies, and has obtained consulting fees from AbbVie, UCB Pharma, Esaote SpA, Bristol-Myers Squibb, Novartis, and Merck Sharp & Dohme. P. Macchioni, MD, Azienda USL-IRCCS di Reggio Emilia; C. Salvarani, MD, Azienda USL-IRCCS di Reggio Emilia, and Università di Modena e Reggio Emilia; N. Possemato, MD, Azienda USL-IRCCS di Reggio Emilia; M. Gutierrez, MD, Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation; W. Grassi, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; S. Gasparini, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; C. Perricone, MD, Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University; F.M. Perrotta, MD, Dipartimento di Medicina e Scienze della Salute, Università degli studi del Molise; R.D. Grembiale, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Bruno, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Tripolino, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; M. Govoni, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; G. Ciancio, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; I. Farina, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; R. Ramonda, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; P. Frallonardo, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; F. Desiati, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO; R. Scarpa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; L. Costa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; A. Zabotti, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; S. De Vita, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; R.M. D’Attino, MD, AbbVie Srl; G. Gualberti, PhD, AbbVie Srl; R. Merolla, MD, AbbVie Srl; U. di Luzio Paparatti, MD, AbbVie Srl; R. Aldigeri, BSc, Department of Medicine and Surgery, University of Parma; A. Marchesoni, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO. Address correspondence to Dr. A. Marchesoni, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO, Piazza Andrea Ferrari 1, 20122 Milan, Italy. E-mail: Antonio.Marchesoni@asst-pini-cto.it. Full Release Article. For details see Reprints and Permissions at jrheum.org Accepted for publication October 29, 2018.
Alen Zabotti
From the Azienda USL-Institute for Research and Health Care (IRCCS) di Reggio Emilia; Università di Modena e Reggio Emilia, Reggio Emilia, Italy; Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation, Mexico City, Mexico; Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani, Jesi; Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University, Rome; Dipartimento di Medicina e Scienze della salute, Università degli studi del Molise, Campobasso; Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro, Catanzaro; Rheumatology Unit, Department of Medical Sciences, University of Ferrara; Azienda Ospedaliero-Universitaria S. Anna — Ferrara; Rheumatology Unit, Department of Medicine DIMED, University of Padua, Padua; Day Hospital of Rheumatology, Azienda Socio Sanitaria Territoriale (ASST) Gaetano Pini-Centro Specialistico Ortopedico (CTO), Milan; Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples; Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia,” Udine; AbbVie Srl, Rome; Department of Medicine and Surgery, University of Parma, Parma, Italy. R.M. D’Attino, G. Gualberti, and R. Merolla are employees of AbbVie and may own AbbVie stocks/options. U. di Luzio Paparatti was an employee of AbbVie and may own AbbVie stocks/options. AbbVie participated in the design, study conduct, and financial support for the study, as well as in interpretation of the data, review, and approval of the manuscript. Dr. C. Salvarani has acted as a consultant for AbbVie, MSD, Pfizer Inc, Roche, Celgene, and Novartis. Dr. W. Grassi has received honoraria and speaker fees from AbbVie, Roche, BMS, Pfizer, UCB, and MSD. Dr. M. Gutierrez has attended advisory board meetings, held scientific consultancies, and has obtained consulting fees from AbbVie, UCB Pharma, Esaote SpA, Bristol-Myers Squibb, Novartis, and Merck Sharp & Dohme. P. Macchioni, MD, Azienda USL-IRCCS di Reggio Emilia; C. Salvarani, MD, Azienda USL-IRCCS di Reggio Emilia, and Università di Modena e Reggio Emilia; N. Possemato, MD, Azienda USL-IRCCS di Reggio Emilia; M. Gutierrez, MD, Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation; W. Grassi, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; S. Gasparini, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; C. Perricone, MD, Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University; F.M. Perrotta, MD, Dipartimento di Medicina e Scienze della Salute, Università degli studi del Molise; R.D. Grembiale, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Bruno, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Tripolino, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; M. Govoni, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; G. Ciancio, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; I. Farina, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; R. Ramonda, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; P. Frallonardo, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; F. Desiati, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO; R. Scarpa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; L. Costa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; A. Zabotti, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; S. De Vita, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; R.M. D’Attino, MD, AbbVie Srl; G. Gualberti, PhD, AbbVie Srl; R. Merolla, MD, AbbVie Srl; U. di Luzio Paparatti, MD, AbbVie Srl; R. Aldigeri, BSc, Department of Medicine and Surgery, University of Parma; A. Marchesoni, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO. Address correspondence to Dr. A. Marchesoni, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO, Piazza Andrea Ferrari 1, 20122 Milan, Italy. E-mail: Antonio.Marchesoni@asst-pini-cto.it. Full Release Article. For details see Reprints and Permissions at jrheum.org Accepted for publication October 29, 2018.
Salvatore De Vita
From the Azienda USL-Institute for Research and Health Care (IRCCS) di Reggio Emilia; Università di Modena e Reggio Emilia, Reggio Emilia, Italy; Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation, Mexico City, Mexico; Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani, Jesi; Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University, Rome; Dipartimento di Medicina e Scienze della salute, Università degli studi del Molise, Campobasso; Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro, Catanzaro; Rheumatology Unit, Department of Medical Sciences, University of Ferrara; Azienda Ospedaliero-Universitaria S. Anna — Ferrara; Rheumatology Unit, Department of Medicine DIMED, University of Padua, Padua; Day Hospital of Rheumatology, Azienda Socio Sanitaria Territoriale (ASST) Gaetano Pini-Centro Specialistico Ortopedico (CTO), Milan; Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples; Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia,” Udine; AbbVie Srl, Rome; Department of Medicine and Surgery, University of Parma, Parma, Italy. R.M. D’Attino, G. Gualberti, and R. Merolla are employees of AbbVie and may own AbbVie stocks/options. U. di Luzio Paparatti was an employee of AbbVie and may own AbbVie stocks/options. AbbVie participated in the design, study conduct, and financial support for the study, as well as in interpretation of the data, review, and approval of the manuscript. Dr. C. Salvarani has acted as a consultant for AbbVie, MSD, Pfizer Inc, Roche, Celgene, and Novartis. Dr. W. Grassi has received honoraria and speaker fees from AbbVie, Roche, BMS, Pfizer, UCB, and MSD. Dr. M. Gutierrez has attended advisory board meetings, held scientific consultancies, and has obtained consulting fees from AbbVie, UCB Pharma, Esaote SpA, Bristol-Myers Squibb, Novartis, and Merck Sharp & Dohme. P. Macchioni, MD, Azienda USL-IRCCS di Reggio Emilia; C. Salvarani, MD, Azienda USL-IRCCS di Reggio Emilia, and Università di Modena e Reggio Emilia; N. Possemato, MD, Azienda USL-IRCCS di Reggio Emilia; M. Gutierrez, MD, Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation; W. Grassi, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; S. Gasparini, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; C. Perricone, MD, Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University; F.M. Perrotta, MD, Dipartimento di Medicina e Scienze della Salute, Università degli studi del Molise; R.D. Grembiale, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Bruno, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Tripolino, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; M. Govoni, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; G. Ciancio, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; I. Farina, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; R. Ramonda, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; P. Frallonardo, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; F. Desiati, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO; R. Scarpa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; L. Costa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; A. Zabotti, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; S. De Vita, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; R.M. D’Attino, MD, AbbVie Srl; G. Gualberti, PhD, AbbVie Srl; R. Merolla, MD, AbbVie Srl; U. di Luzio Paparatti, MD, AbbVie Srl; R. Aldigeri, BSc, Department of Medicine and Surgery, University of Parma; A. Marchesoni, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO. Address correspondence to Dr. A. Marchesoni, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO, Piazza Andrea Ferrari 1, 20122 Milan, Italy. E-mail: Antonio.Marchesoni@asst-pini-cto.it. Full Release Article. For details see Reprints and Permissions at jrheum.org Accepted for publication October 29, 2018.
Rita Maria D’Attino
From the Azienda USL-Institute for Research and Health Care (IRCCS) di Reggio Emilia; Università di Modena e Reggio Emilia, Reggio Emilia, Italy; Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation, Mexico City, Mexico; Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani, Jesi; Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University, Rome; Dipartimento di Medicina e Scienze della salute, Università degli studi del Molise, Campobasso; Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro, Catanzaro; Rheumatology Unit, Department of Medical Sciences, University of Ferrara; Azienda Ospedaliero-Universitaria S. Anna — Ferrara; Rheumatology Unit, Department of Medicine DIMED, University of Padua, Padua; Day Hospital of Rheumatology, Azienda Socio Sanitaria Territoriale (ASST) Gaetano Pini-Centro Specialistico Ortopedico (CTO), Milan; Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples; Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia,” Udine; AbbVie Srl, Rome; Department of Medicine and Surgery, University of Parma, Parma, Italy. R.M. D’Attino, G. Gualberti, and R. Merolla are employees of AbbVie and may own AbbVie stocks/options. U. di Luzio Paparatti was an employee of AbbVie and may own AbbVie stocks/options. AbbVie participated in the design, study conduct, and financial support for the study, as well as in interpretation of the data, review, and approval of the manuscript. Dr. C. Salvarani has acted as a consultant for AbbVie, MSD, Pfizer Inc, Roche, Celgene, and Novartis. Dr. W. Grassi has received honoraria and speaker fees from AbbVie, Roche, BMS, Pfizer, UCB, and MSD. Dr. M. Gutierrez has attended advisory board meetings, held scientific consultancies, and has obtained consulting fees from AbbVie, UCB Pharma, Esaote SpA, Bristol-Myers Squibb, Novartis, and Merck Sharp & Dohme. P. Macchioni, MD, Azienda USL-IRCCS di Reggio Emilia; C. Salvarani, MD, Azienda USL-IRCCS di Reggio Emilia, and Università di Modena e Reggio Emilia; N. Possemato, MD, Azienda USL-IRCCS di Reggio Emilia; M. Gutierrez, MD, Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation; W. Grassi, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; S. Gasparini, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; C. Perricone, MD, Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University; F.M. Perrotta, MD, Dipartimento di Medicina e Scienze della Salute, Università degli studi del Molise; R.D. Grembiale, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Bruno, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Tripolino, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; M. Govoni, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; G. Ciancio, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; I. Farina, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; R. Ramonda, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; P. Frallonardo, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; F. Desiati, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO; R. Scarpa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; L. Costa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; A. Zabotti, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; S. De Vita, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; R.M. D’Attino, MD, AbbVie Srl; G. Gualberti, PhD, AbbVie Srl; R. Merolla, MD, AbbVie Srl; U. di Luzio Paparatti, MD, AbbVie Srl; R. Aldigeri, BSc, Department of Medicine and Surgery, University of Parma; A. Marchesoni, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO. Address correspondence to Dr. A. Marchesoni, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO, Piazza Andrea Ferrari 1, 20122 Milan, Italy. E-mail: Antonio.Marchesoni@asst-pini-cto.it. Full Release Article. For details see Reprints and Permissions at jrheum.org Accepted for publication October 29, 2018.
Giuliana Gualberti
From the Azienda USL-Institute for Research and Health Care (IRCCS) di Reggio Emilia; Università di Modena e Reggio Emilia, Reggio Emilia, Italy; Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation, Mexico City, Mexico; Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani, Jesi; Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University, Rome; Dipartimento di Medicina e Scienze della salute, Università degli studi del Molise, Campobasso; Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro, Catanzaro; Rheumatology Unit, Department of Medical Sciences, University of Ferrara; Azienda Ospedaliero-Universitaria S. Anna — Ferrara; Rheumatology Unit, Department of Medicine DIMED, University of Padua, Padua; Day Hospital of Rheumatology, Azienda Socio Sanitaria Territoriale (ASST) Gaetano Pini-Centro Specialistico Ortopedico (CTO), Milan; Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples; Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia,” Udine; AbbVie Srl, Rome; Department of Medicine and Surgery, University of Parma, Parma, Italy. R.M. D’Attino, G. Gualberti, and R. Merolla are employees of AbbVie and may own AbbVie stocks/options. U. di Luzio Paparatti was an employee of AbbVie and may own AbbVie stocks/options. AbbVie participated in the design, study conduct, and financial support for the study, as well as in interpretation of the data, review, and approval of the manuscript. Dr. C. Salvarani has acted as a consultant for AbbVie, MSD, Pfizer Inc, Roche, Celgene, and Novartis. Dr. W. Grassi has received honoraria and speaker fees from AbbVie, Roche, BMS, Pfizer, UCB, and MSD. Dr. M. Gutierrez has attended advisory board meetings, held scientific consultancies, and has obtained consulting fees from AbbVie, UCB Pharma, Esaote SpA, Bristol-Myers Squibb, Novartis, and Merck Sharp & Dohme. P. Macchioni, MD, Azienda USL-IRCCS di Reggio Emilia; C. Salvarani, MD, Azienda USL-IRCCS di Reggio Emilia, and Università di Modena e Reggio Emilia; N. Possemato, MD, Azienda USL-IRCCS di Reggio Emilia; M. Gutierrez, MD, Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation; W. Grassi, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; S. Gasparini, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; C. Perricone, MD, Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University; F.M. Perrotta, MD, Dipartimento di Medicina e Scienze della Salute, Università degli studi del Molise; R.D. Grembiale, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Bruno, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Tripolino, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; M. Govoni, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; G. Ciancio, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; I. Farina, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; R. Ramonda, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; P. Frallonardo, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; F. Desiati, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO; R. Scarpa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; L. Costa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; A. Zabotti, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; S. De Vita, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; R.M. D’Attino, MD, AbbVie Srl; G. Gualberti, PhD, AbbVie Srl; R. Merolla, MD, AbbVie Srl; U. di Luzio Paparatti, MD, AbbVie Srl; R. Aldigeri, BSc, Department of Medicine and Surgery, University of Parma; A. Marchesoni, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO. Address correspondence to Dr. A. Marchesoni, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO, Piazza Andrea Ferrari 1, 20122 Milan, Italy. E-mail: Antonio.Marchesoni@asst-pini-cto.it. Full Release Article. For details see Reprints and Permissions at jrheum.org Accepted for publication October 29, 2018.
Rocco Merolla
From the Azienda USL-Institute for Research and Health Care (IRCCS) di Reggio Emilia; Università di Modena e Reggio Emilia, Reggio Emilia, Italy; Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation, Mexico City, Mexico; Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani, Jesi; Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University, Rome; Dipartimento di Medicina e Scienze della salute, Università degli studi del Molise, Campobasso; Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro, Catanzaro; Rheumatology Unit, Department of Medical Sciences, University of Ferrara; Azienda Ospedaliero-Universitaria S. Anna — Ferrara; Rheumatology Unit, Department of Medicine DIMED, University of Padua, Padua; Day Hospital of Rheumatology, Azienda Socio Sanitaria Territoriale (ASST) Gaetano Pini-Centro Specialistico Ortopedico (CTO), Milan; Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples; Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia,” Udine; AbbVie Srl, Rome; Department of Medicine and Surgery, University of Parma, Parma, Italy. R.M. D’Attino, G. Gualberti, and R. Merolla are employees of AbbVie and may own AbbVie stocks/options. U. di Luzio Paparatti was an employee of AbbVie and may own AbbVie stocks/options. AbbVie participated in the design, study conduct, and financial support for the study, as well as in interpretation of the data, review, and approval of the manuscript. Dr. C. Salvarani has acted as a consultant for AbbVie, MSD, Pfizer Inc, Roche, Celgene, and Novartis. Dr. W. Grassi has received honoraria and speaker fees from AbbVie, Roche, BMS, Pfizer, UCB, and MSD. Dr. M. Gutierrez has attended advisory board meetings, held scientific consultancies, and has obtained consulting fees from AbbVie, UCB Pharma, Esaote SpA, Bristol-Myers Squibb, Novartis, and Merck Sharp & Dohme. P. Macchioni, MD, Azienda USL-IRCCS di Reggio Emilia; C. Salvarani, MD, Azienda USL-IRCCS di Reggio Emilia, and Università di Modena e Reggio Emilia; N. Possemato, MD, Azienda USL-IRCCS di Reggio Emilia; M. Gutierrez, MD, Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation; W. Grassi, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; S. Gasparini, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; C. Perricone, MD, Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University; F.M. Perrotta, MD, Dipartimento di Medicina e Scienze della Salute, Università degli studi del Molise; R.D. Grembiale, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Bruno, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Tripolino, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; M. Govoni, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; G. Ciancio, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; I. Farina, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; R. Ramonda, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; P. Frallonardo, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; F. Desiati, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO; R. Scarpa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; L. Costa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; A. Zabotti, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; S. De Vita, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; R.M. D’Attino, MD, AbbVie Srl; G. Gualberti, PhD, AbbVie Srl; R. Merolla, MD, AbbVie Srl; U. di Luzio Paparatti, MD, AbbVie Srl; R. Aldigeri, BSc, Department of Medicine and Surgery, University of Parma; A. Marchesoni, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO. Address correspondence to Dr. A. Marchesoni, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO, Piazza Andrea Ferrari 1, 20122 Milan, Italy. E-mail: Antonio.Marchesoni@asst-pini-cto.it. Full Release Article. For details see Reprints and Permissions at jrheum.org Accepted for publication October 29, 2018.
Umberto di Luzio Paparatti
From the Azienda USL-Institute for Research and Health Care (IRCCS) di Reggio Emilia; Università di Modena e Reggio Emilia, Reggio Emilia, Italy; Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation, Mexico City, Mexico; Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani, Jesi; Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University, Rome; Dipartimento di Medicina e Scienze della salute, Università degli studi del Molise, Campobasso; Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro, Catanzaro; Rheumatology Unit, Department of Medical Sciences, University of Ferrara; Azienda Ospedaliero-Universitaria S. Anna — Ferrara; Rheumatology Unit, Department of Medicine DIMED, University of Padua, Padua; Day Hospital of Rheumatology, Azienda Socio Sanitaria Territoriale (ASST) Gaetano Pini-Centro Specialistico Ortopedico (CTO), Milan; Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples; Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia,” Udine; AbbVie Srl, Rome; Department of Medicine and Surgery, University of Parma, Parma, Italy. R.M. D’Attino, G. Gualberti, and R. Merolla are employees of AbbVie and may own AbbVie stocks/options. U. di Luzio Paparatti was an employee of AbbVie and may own AbbVie stocks/options. AbbVie participated in the design, study conduct, and financial support for the study, as well as in interpretation of the data, review, and approval of the manuscript. Dr. C. Salvarani has acted as a consultant for AbbVie, MSD, Pfizer Inc, Roche, Celgene, and Novartis. Dr. W. Grassi has received honoraria and speaker fees from AbbVie, Roche, BMS, Pfizer, UCB, and MSD. Dr. M. Gutierrez has attended advisory board meetings, held scientific consultancies, and has obtained consulting fees from AbbVie, UCB Pharma, Esaote SpA, Bristol-Myers Squibb, Novartis, and Merck Sharp & Dohme. P. Macchioni, MD, Azienda USL-IRCCS di Reggio Emilia; C. Salvarani, MD, Azienda USL-IRCCS di Reggio Emilia, and Università di Modena e Reggio Emilia; N. Possemato, MD, Azienda USL-IRCCS di Reggio Emilia; M. Gutierrez, MD, Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation; W. Grassi, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; S. Gasparini, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; C. Perricone, MD, Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University; F.M. Perrotta, MD, Dipartimento di Medicina e Scienze della Salute, Università degli studi del Molise; R.D. Grembiale, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Bruno, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Tripolino, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; M. Govoni, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; G. Ciancio, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; I. Farina, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; R. Ramonda, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; P. Frallonardo, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; F. Desiati, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO; R. Scarpa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; L. Costa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; A. Zabotti, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; S. De Vita, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; R.M. D’Attino, MD, AbbVie Srl; G. Gualberti, PhD, AbbVie Srl; R. Merolla, MD, AbbVie Srl; U. di Luzio Paparatti, MD, AbbVie Srl; R. Aldigeri, BSc, Department of Medicine and Surgery, University of Parma; A. Marchesoni, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO. Address correspondence to Dr. A. Marchesoni, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO, Piazza Andrea Ferrari 1, 20122 Milan, Italy. E-mail: Antonio.Marchesoni@asst-pini-cto.it. Full Release Article. For details see Reprints and Permissions at jrheum.org Accepted for publication October 29, 2018.
Raffaella Aldigeri
From the Azienda USL-Institute for Research and Health Care (IRCCS) di Reggio Emilia; Università di Modena e Reggio Emilia, Reggio Emilia, Italy; Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation, Mexico City, Mexico; Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani, Jesi; Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University, Rome; Dipartimento di Medicina e Scienze della salute, Università degli studi del Molise, Campobasso; Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro, Catanzaro; Rheumatology Unit, Department of Medical Sciences, University of Ferrara; Azienda Ospedaliero-Universitaria S. Anna — Ferrara; Rheumatology Unit, Department of Medicine DIMED, University of Padua, Padua; Day Hospital of Rheumatology, Azienda Socio Sanitaria Territoriale (ASST) Gaetano Pini-Centro Specialistico Ortopedico (CTO), Milan; Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples; Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia,” Udine; AbbVie Srl, Rome; Department of Medicine and Surgery, University of Parma, Parma, Italy. R.M. D’Attino, G. Gualberti, and R. Merolla are employees of AbbVie and may own AbbVie stocks/options. U. di Luzio Paparatti was an employee of AbbVie and may own AbbVie stocks/options. AbbVie participated in the design, study conduct, and financial support for the study, as well as in interpretation of the data, review, and approval of the manuscript. Dr. C. Salvarani has acted as a consultant for AbbVie, MSD, Pfizer Inc, Roche, Celgene, and Novartis. Dr. W. Grassi has received honoraria and speaker fees from AbbVie, Roche, BMS, Pfizer, UCB, and MSD. Dr. M. Gutierrez has attended advisory board meetings, held scientific consultancies, and has obtained consulting fees from AbbVie, UCB Pharma, Esaote SpA, Bristol-Myers Squibb, Novartis, and Merck Sharp & Dohme. P. Macchioni, MD, Azienda USL-IRCCS di Reggio Emilia; C. Salvarani, MD, Azienda USL-IRCCS di Reggio Emilia, and Università di Modena e Reggio Emilia; N. Possemato, MD, Azienda USL-IRCCS di Reggio Emilia; M. Gutierrez, MD, Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation; W. Grassi, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; S. Gasparini, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; C. Perricone, MD, Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University; F.M. Perrotta, MD, Dipartimento di Medicina e Scienze della Salute, Università degli studi del Molise; R.D. Grembiale, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Bruno, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Tripolino, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; M. Govoni, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; G. Ciancio, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; I. Farina, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; R. Ramonda, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; P. Frallonardo, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; F. Desiati, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO; R. Scarpa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; L. Costa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; A. Zabotti, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; S. De Vita, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; R.M. D’Attino, MD, AbbVie Srl; G. Gualberti, PhD, AbbVie Srl; R. Merolla, MD, AbbVie Srl; U. di Luzio Paparatti, MD, AbbVie Srl; R. Aldigeri, BSc, Department of Medicine and Surgery, University of Parma; A. Marchesoni, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO. Address correspondence to Dr. A. Marchesoni, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO, Piazza Andrea Ferrari 1, 20122 Milan, Italy. E-mail: Antonio.Marchesoni@asst-pini-cto.it. Full Release Article. For details see Reprints and Permissions at jrheum.org Accepted for publication October 29, 2018.
Antonio Marchesoni
From the Azienda USL-Institute for Research and Health Care (IRCCS) di Reggio Emilia; Università di Modena e Reggio Emilia, Reggio Emilia, Italy; Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation, Mexico City, Mexico; Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani, Jesi; Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University, Rome; Dipartimento di Medicina e Scienze della salute, Università degli studi del Molise, Campobasso; Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro, Catanzaro; Rheumatology Unit, Department of Medical Sciences, University of Ferrara; Azienda Ospedaliero-Universitaria S. Anna — Ferrara; Rheumatology Unit, Department of Medicine DIMED, University of Padua, Padua; Day Hospital of Rheumatology, Azienda Socio Sanitaria Territoriale (ASST) Gaetano Pini-Centro Specialistico Ortopedico (CTO), Milan; Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples; Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia,” Udine; AbbVie Srl, Rome; Department of Medicine and Surgery, University of Parma, Parma, Italy. R.M. D’Attino, G. Gualberti, and R. Merolla are employees of AbbVie and may own AbbVie stocks/options. U. di Luzio Paparatti was an employee of AbbVie and may own AbbVie stocks/options. AbbVie participated in the design, study conduct, and financial support for the study, as well as in interpretation of the data, review, and approval of the manuscript. Dr. C. Salvarani has acted as a consultant for AbbVie, MSD, Pfizer Inc, Roche, Celgene, and Novartis. Dr. W. Grassi has received honoraria and speaker fees from AbbVie, Roche, BMS, Pfizer, UCB, and MSD. Dr. M. Gutierrez has attended advisory board meetings, held scientific consultancies, and has obtained consulting fees from AbbVie, UCB Pharma, Esaote SpA, Bristol-Myers Squibb, Novartis, and Merck Sharp & Dohme. P. Macchioni, MD, Azienda USL-IRCCS di Reggio Emilia; C. Salvarani, MD, Azienda USL-IRCCS di Reggio Emilia, and Università di Modena e Reggio Emilia; N. Possemato, MD, Azienda USL-IRCCS di Reggio Emilia; M. Gutierrez, MD, Division of MSK and Rheumatic Disorders, National Institute of Rehabilitation; W. Grassi, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; S. Gasparini, MD, Rheumatology Unit, Università Politecnica delle Marche Ospedale C. Urbani; C. Perricone, MD, Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University; F.M. Perrotta, MD, Dipartimento di Medicina e Scienze della Salute, Università degli studi del Molise; R.D. Grembiale, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Bruno, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; C. Tripolino, MD, Rheumatology Research Unit, Dipartimento di Scienze della Salute, Università “Magna Graecia” di Catanzaro; M. Govoni, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; G. Ciancio, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; I. Farina, MD, Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Azienda Ospedaliero-Universitaria S. Anna; R. Ramonda, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; P. Frallonardo, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; F. Desiati, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO; R. Scarpa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; L. Costa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; A. Zabotti, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; S. De Vita, MD, Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”; R.M. D’Attino, MD, AbbVie Srl; G. Gualberti, PhD, AbbVie Srl; R. Merolla, MD, AbbVie Srl; U. di Luzio Paparatti, MD, AbbVie Srl; R. Aldigeri, BSc, Department of Medicine and Surgery, University of Parma; A. Marchesoni, MD, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO. Address correspondence to Dr. A. Marchesoni, Day Hospital of Rheumatology, ASST Gaetano Pini-CTO, Piazza Andrea Ferrari 1, 20122 Milan, Italy. E-mail: Antonio.Marchesoni@asst-pini-cto.it. Full Release Article. For details see Reprints and Permissions at jrheum.org Accepted for publication October 29, 2018.
Article Figures & Data
Additional Files
Data Supplement
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Ultrasonographic and Clinical Assessment of Peripheral Enthesitis in Patients with Psoriatic Arthritis, Psoriasis, and Fibromyalgia Syndrome: The ULISSE Study
Pierluigi Macchioni, Carlo Salvarani, Niccolò Possemato, Marwin Gutierrez, Walter Grassi, Stefania Gasparini, Carlo Perricone, Fabio Massimo Perrotta, Rosa Daniela Grembiale, Caterina Bruno, Cesare Tripolino, Marcello Govoni, Giovanni Ciancio, Ilaria Farina, Roberta Ramonda, Paola Frallonardo, Francesca Desiati, Raffaele Scarpa, Luisa Costa, Alen Zabotti, Salvatore De Vita, Rita Maria D’Attino, Giuliana Gualberti, Rocco Merolla, Umberto di Luzio Paparatti, Raffaella Aldigeri, Antonio Marchesoni
The Journal of Rheumatology Mar 2019, jrheum.171411; DOI: 10.3899/jrheum.171411
Ultrasonographic and Clinical Assessment of Peripheral Enthesitis in Patients with Psoriatic Arthritis, Psoriasis, and Fibromyalgia Syndrome: The ULISSE Study
Pierluigi Macchioni, Carlo Salvarani, Niccolò Possemato, Marwin Gutierrez, Walter Grassi, Stefania Gasparini, Carlo Perricone, Fabio Massimo Perrotta, Rosa Daniela Grembiale, Caterina Bruno, Cesare Tripolino, Marcello Govoni, Giovanni Ciancio, Ilaria Farina, Roberta Ramonda, Paola Frallonardo, Francesca Desiati, Raffaele Scarpa, Luisa Costa, Alen Zabotti, Salvatore De Vita, Rita Maria D’Attino, Giuliana Gualberti, Rocco Merolla, Umberto di Luzio Paparatti, Raffaella Aldigeri, Antonio Marchesoni
The Journal of Rheumatology Mar 2019, jrheum.171411; DOI: 10.3899/jrheum.171411